期刊文献+

个性化营养干预对痛风患者患因及预后的影响

Effect of Personalized Nutrition Intervention on the Risk Factors and Prognosis of Gout
下载PDF
导出
摘要 为探讨个性化营养干预及健康管理对痛风患者高尿酸血症及体质的影响,选取2022年1月~12月门诊就诊且具有强烈非药物治疗意愿的82例男性痛风患者,随机均分为对照组和实验组。对照组接受生活方式干预,实验组接受个性化营养干预,干预时间为3个月。研究表明,研究区痛风发病率更高、更年轻化。干预后,对照组身体质量指数、腰围及血清尿酸均有所下降,其他指标无明显变化;实验组身体质量指数、腰围、血清尿酸及血脂等均出现明显下降,大部分患者血清尿酸降至正常范围。因此,个性化营养干预能有效改善痛风患者的营养健康状况,降低其血清尿酸水平,有助于提升预后效果。 82 male gout patients who had outpatient visits from January to December 2022 and expressed a strong desire for non-pharmacological treatment were selected and randomly divided into a control group and an experimental group to investigate the impact of personalized nutritional intervention and health management on hyperuricemia and physical fitness in gout patients.The control group received lifestyle intervention,while the experimental group underwent personalized nutritional intervention for a period of 3 months.The research shows that the incidence of gout is higher and occurs at a younger age in the study area.The body mass index,waist circumference,and serum uric acid level of the control group decrease,while other indicators do not show significant changes after the intervention.The body mass index,waist circumference,serum uric acid,and blood lipids of the experimental group significantly decrease,with the serum uric acid levels of most patients returning to the normal range.Thus,personalized nutritional intervention can effectively enhance the nutritional health status of gout patients,reduce serum uric acid levels,and contribute to improved prognosis.
作者 孙珊珊 李振云 马纪蕾 王爱敏 SUN Shan-shan;LI Zhen-yun;MA Ji-lei;WANG Ai-min(Internal Medicine Department of Affiliated Hospital,Qingdao University,Qingdao 266000,China;School of Nursing,Qingdao University,Qingdao 266000,China)
出处 《青岛大学学报(自然科学版)》 CAS 2024年第2期15-21,共7页 Journal of Qingdao University(Natural Science Edition)
基金 山东省自然科学基金(批准号:ZR2023MG071)资助。
关键词 痛风 高尿酸血症 营养干预 非药物治疗 gout hyperuricemia nutrition intervention non-pharmacological treatment
  • 相关文献

参考文献5

二级参考文献63

  • 1王滟,刘治军,潘琦,居阳.促尿酸排泄剂导致痛风急性发作[J].临床误诊误治,2005,18(9):640-641. 被引量:1
  • 2Hershfield MS, Callaghan JT, Tassaneeyakul W, etal. Clini- cal pharrnacogenetics implementation consortium guidelines for human leukocyte antigen-B genotype and allopurinol do sing[J]. Clin Pharmacol Ther, 2013,93 (2) : 153-158.
  • 3国家食品药品监督管理局.食品药品监管总局提醒关注苯溴马隆的肝损害风险[EB/OL].http://www.sfda.gov.cn/wS01/CL0078/111881.html,2014-12-31.
  • 4Suggested definitions and relationships among medication mis ad ventures, medication errors, adverse drug events, and ad verse drug reactions[J]. Am J Health-Syst Pharm, 1998,55 165 66.
  • 5Suzuki T, Suzuki T, Kimura M, et al. A case of fulminant hepa- titis, possibly caused by benzbromarone[J]. Nihon Shokakibyo Gakkai Zasshi. 2001,98 (4) : 421-425.
  • 6Wagayama H, Shiraki K, Sugimoto K, et al. Fatal fulminant he- patic failure associated with benzbromarone[J]. Hepatol. 2000, 32(5) : 874.
  • 7Arai M, Yokosuka O, Fuiiwara K, et al. Fulminant hepatic fail- ure associated with henzbromarone treatment a case report [J]. Gastroenterol Hepatol. 2002,17(5) :625-626.
  • 8Klauw MMVD, Houtman PM, Stricker BH,et al. Hepatic in- jury caused by benzbromarone[J]. Hepatol. 1994, 20 (3) : 376- 379.
  • 9Haring B,Kudlich T,Rauthe S,et al. 13enzbromarone: a doub- leedged sword that cuts the liver? [J]. Eur J Gastroenterol Hepatol. 2013,25(l) : 119-121.
  • 10樊贺明.口服苯溴马隆片引起的多形性红斑1例[J].中国保健营养.2014,2(中):672.

共引文献128

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部